Targeted therapies in R/R myeloma: novel approaches being explored

Targeted therapies in R/R myeloma: novel approaches being explored

Myeloma 2015 round table: Novel targeted therapies in myelomaПодробнее

Myeloma 2015 round table: Novel targeted therapies in myeloma

What targets are being explored for antibody therapy? #myelomaПодробнее

What targets are being explored for antibody therapy? #myeloma

Novel Approaches for the Treatment of Classical HLПодробнее

Novel Approaches for the Treatment of Classical HL

How do I treat patients with RRMM after failure of BCMA-targeted therapies?Подробнее

How do I treat patients with RRMM after failure of BCMA-targeted therapies?

Rethinking Breast Cancer: Optimal Trial Design and Exploring Novel ModalitiesПодробнее

Rethinking Breast Cancer: Optimal Trial Design and Exploring Novel Modalities

Novel Treatment Strategies in R/R Multiple MyelomaПодробнее

Novel Treatment Strategies in R/R Multiple Myeloma

GPRC5D and FCRH5 Targeted Therapies in MyelomaПодробнее

GPRC5D and FCRH5 Targeted Therapies in Myeloma

Novel targets and dual-targeting approaches in myelomaПодробнее

Novel targets and dual-targeting approaches in myeloma

Novel targets being explored in multiple myeloma and the value of CELMoDsПодробнее

Novel targets being explored in multiple myeloma and the value of CELMoDs

What is the difference between classical chemotherapy and novel targeted therapy? #myelomaПодробнее

What is the difference between classical chemotherapy and novel targeted therapy? #myeloma

Dr. Lonial Discusses Novel Agents in Multiple MyelomaПодробнее

Dr. Lonial Discusses Novel Agents in Multiple Myeloma

Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer InstituteПодробнее

Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer Institute

Managing progression after BCMA-targeted therapy in R/R multiple myelomaПодробнее

Managing progression after BCMA-targeted therapy in R/R multiple myeloma

Upcoming therapeutic approaches in the R/R myeloma spaceПодробнее

Upcoming therapeutic approaches in the R/R myeloma space

Using BCMA-targeting agents in earlier lines of treatment for multiple myelomaПодробнее

Using BCMA-targeting agents in earlier lines of treatment for multiple myeloma

Novel agents in myeloma: different targets and mechanisms of actionПодробнее

Novel agents in myeloma: different targets and mechanisms of action

Reaching the Next Level of Myeloma Patient Care: Antibody Therapy and Novel Mechanisms of ActionПодробнее

Reaching the Next Level of Myeloma Patient Care: Antibody Therapy and Novel Mechanisms of Action

BCMA-Targeted Therapies in Multiple MyelomaПодробнее

BCMA-Targeted Therapies in Multiple Myeloma

Analyzing the Outcomes With Different Treatment Techniques in MyelomaПодробнее

Analyzing the Outcomes With Different Treatment Techniques in Myeloma